Drug Search Results
More Filters [+]

ABT-510

Alternative Names: abt-510, abt510, abt 510
Latest Update: 2023-05-09
Latest Update Note: PubMed Publication

Product Description

ABT-510 is a small peptide thrombospondin-1 mimetic angiogenesis inhibitor under development by Abbott Laboratories for the potential treatment of solid tumors. ABT-510 is undergoing phase II clinical trials. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/15468604/)

Mechanisms of Action: Angiogenesis Inhibitor

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Subcutaneous,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Abbott Laboratories
Company Location: ABBOTT PARK IL 60064-3500
Company CEO: Robert B. Ford
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ABT-510

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Lymphoma, Non-Hodgkin|Renal Cell Carcinoma|Head and Neck Cancer|Melanoma|Sarcoma|Non-Small-Cell Lung Cancer

Phase 1: Brain Cancer|Glioblastoma|Ischemic Attack, Transient|Hypertension, Renal|Myocardial Infarction|Edema|Skin Cancer|Constipation|Low Back Pain|Diarrhea|Dyspnea|Small Cell Lung Cancer|Angina, Stable|Headache|Peripheral Arterial Disease|Colorectal Cancer|Vascular Cancer|Ovarian Cancer|Anorexia|Dizziness|Glioma|Insomnia|Anemia|Abdominal Pain|Angina, Unstable|Breast Cancer|Asthenia|Chest Pain|Non-Small-Cell Lung Cancer|Kidney Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Pro00008797

P1

Completed

Constipation|Skin Cancer|Asthenia|Peripheral Arterial Disease|Diarrhea|Low Back Pain|Chest Pain|Hypertension, Renal|Breast Cancer|Dizziness|Angina, Unstable|Kidney Diseases|Small Cell Lung Cancer|Non-Small-Cell Lung Cancer|Insomnia|Edema|Ischemic Attack, Transient|Myocardial Infarction|Abdominal Pain|Angina, Stable|Headache|Colorectal Cancer|Anorexia|Anemia|Glioma|Dyspnea|Ovarian Cancer|Vascular Cancer

2013-02-01

UAB 0327

P1

Completed

Glioblastoma|Brain Cancer

2008-07-01

NCT00113334

P2

Completed

Head and Neck Cancer

2008-03-01

CDR0000582475

P2

Completed

Melanoma

2005-06-01

Recent News Events